Two closely related genes have been identified at 2q13 and 22q13.3. These genes show similarity to members of the RAB family of small GTPases. RABL2A and RABL2B differ by three conservative amino acid changes over a total of 228 residues. Both are expressed in all tissues tested. Northern analysis showed that a 2.5-kb transcript is expressed in all tissues tested while a 1.4-kb transcript is specifically expressed only in muscle. The size difference between these two transcripts is the result of differential splicing of an intron within the 3 UTR. RABL2B is located within the subtelomeric region of 22q13.3. RABL2A maps to 2q13, the site of an ancestral telomere fusion event, suggesting that it also may be a subtelomeric gene.
INTRODUCTION
The subtelomeric region of human chromosomes contains a variety of repeated sequences adjacent to the terminal (TTAGGG) n telomeric repeat. The sequence proximal to the subtelomeric region is unique to each chromosome. A comparison of the subtelomeric regions of human chromosomes 16p, 4p, and 22q revealed an overall structure of these regions with distinct domains similar to those found in yeast . The subtelomeric region can be divided into proximal and distal domains, which are separated by a boundary element composed of degenerate (TTAGGG) n repeats and putative origin of replication consensus sequences. The distal domain adjacent to the telomere has short interrupted regions of homology to many different chromosome ends. This domain contains many partial matches to ESTs, which presumably represent pseudogenes since no corresponding transcripts were found by RT-PCR. Alternatively, the proximal domain shows long continuous regions of homology with a small number of different chromosome ends. In humans, subtelomeric regions are the location of members of many gene families. These include olfactory receptors (Trask et al., 1998) , IL-9 receptors (Kermouni et al., 1995) , and Chl1-related helicases (Amann et al., 1996) . Only the IL-9 receptor on Xq28/Yq12 is known to be active; the sequence of one olfactory receptor indicates that it is potentially active, and all the rest appear to be pseudogenes. In addition, an active zinc finger gene at 4pter appears to span the boundary of the proximal subtelomeric domain and unique sequence, with its 5Ј end in the unique sequence region .
Subtelomeric regions show a dynamic nature. Stable length polymorphisms of the subtelomeric region of chromosome 16p revealed different terminal segments, each containing repeats homologous to those found on other nonhomologous chromosomes (Wilkie et al., 1991) . The exchange of repeats between the subtelomeric regions of 4q and 10q is present in 20% of the population (van Deutekom et al., 1996) . A segment originally present at 17qter shows evidence of recent spreading to multiple subtelomeric domains (Monfouilloux et al., 1998) . The olfactory receptor pseudogenes show considerable polymorphism in both copy number and subtelomeric chromosome location (Trask et al., 1998) . These observations suggest that repeats and gene family members spread by nonhomologous exchanges between the subtelomeric regions.
The chromosome 22 distal subtelomeric domain (which shows interrupted homology to many different chromosome ends including 1q, 4p, 7p, 14q, 15q, 17q, 18p, 21q, and Xq) and the adjacent degenerate (TTAGGG) n boundary element have been well delineated . The proximal domain has been less well characterized; however, a cosmid (c202) that maps proximal to the boundary element was shown by FISH to hybridize to both 22qter and 2q13 (Ning et al., 1996) . Since the latter is also the location of an ancestral telomeric region formed from the fusion of two ancestral ape chromosomes (Ijdo et al., 1991) , this suggests that c202 contains the 22qter proximal subtelomeric repeat region that is duplicated at the ancestral telomeric region of 2q13.
We are currently mapping genes within a 130-kb terminal microdeletion of chromosome 22q (Wong et al., 1997 ) in a patient who shows expressive speech delay and mild mental retardation , a subset of features seen in the larger deletions of the 22q13.3 deletion syndrome (Nesslinger et al., 1994) . By analyzing the sequence of a cosmid contig spanning the deletion, we have mapped a gene that is located directly adjacent to the subtelomeric degenerate (TTAGGG) n boundary element and therefore in the putative proximal domain of the subtelomeric region of 22q. As expected, a closely related copy of this gene was found at 2q13. Both genes share similarity to the RAB family of GTPases, which are involved in the control of vesicular trafficking in cells (reviewed by Lazar et al., 1997; Novick and Zerial, 1997; Olkkonen and Stenmark, 1997 ). These RAB-like genes on chromosome 2 (RABL2A) and chromosome 22 (RABL2B) differ by three conservative amino acid changes and are both expressed. Therefore, the RABL2 genes may represent the first example of duplicated genes in human proximal subtelomeric regions that are both actively expressed.
MATERIALS AND METHODS
Cell lines. Cell lines from the human/rodent somatic cell hybrid mapping panel 2 and a normal human lymphoblastoid cell line (GM03657) were obtained from the NIGMS Human Genetic Mutant Cell Repository. RJK88 is a hamster fibroblast line (Fuscoe et al., 1983) .
Sequence analysis of cosmid N1G3. Human genomic cosmid clone N1G3 was isolated from the chromosome 22-specific library LL22NC03 as previously described (Wong et al., 1997) . It was sequenced (GenBank Accession No. AC002055) by a random shotgun strategy (protocol available from http://www.genome.ou.edu). The sequence was searched against various public databases through BLASTN and BLASTP programs in BCM Launcher (http://gc.bcm. tmc.edu:8088/search-launcher.html).
Sequencing of cDNA clones. Soares pregnant uterus NbHPU library cDNA clone 504484 (Accession Nos. AA150066 and AA149886 for the 5Ј and 3Ј sequences in the EST database, respectively) and three cDNA clones generated by 3Ј rapid amplification of cDNA ends (RACE) (see below) were sequenced using the Thermo Sequenase radiolabeled terminator cycle sequencing kit (Amersham). For the 504484 clone, sequencing started from both ends using T7 and T3 primers. Gaps inside the insert were filled by sequencing with the internal primers pul51 (5Ј CCA GAG CAT GCA TGC CTC CT 3Ј, nucleotides 402-421 in Fig. 3 ) and pul32 (5Ј GGG AGT TCT GTT TGT AAG ACA C 3Ј, nucleotides 706 -685 in Fig. 3 ). For the 3ЈRACE clone hc5, sequencing started from both ends using pul51 and Gibco BRL Universal Amplification primer (5Ј GGC CAC GCG TCG ACT AGT AC 3Ј). Gaps inside the insert were filled using internal primers pul31 (5Ј CAT ACT AGC AAG CCA CAA GTA C 3Ј, nucleotides 1969 -1944) , E1.03F (5Ј TTC CTT GGG CTT CTC CTG AG 3Ј, nucleotides 1238 -1258), and E0.91F (5Ј TCC TCT GAT GGG GTC TCG AT 3Ј, nucleotides 818 -799). For the 3ЈRACE clones hc7 and hc8, sequencing started from both ends by using pul51 and pul31 primers, and the gap was filled by sequencing with E0.91F.
Hybrid panel analysis. DNAs isolated from the NIGMS Human
Genetics Mutant Cell Repository human/rodent somatic cell hybrid mapping panel 2, normal human lymphoblastoid cell line (GM03657), and hamster cell line RJK88 were digested with HindIII, electrophoresed on a 0.8% agarose gel, and blotted onto nylon membranes (Gene Screen Plus, Du Pont). cDNA 504484 was labeled by the conventional random-priming method (Feinberg and Vogelstein, 1983 ) and hybridized to the monochromosomal hybrid panels. To characterize further the genomic regions where RABL2A and RABL2B are located, a partial hybrid panel Southern blot was prepared with DNAs isolated from cell lines GM/NA10826B (chromosome 2 hybrid cell line), GM/NA10888 (chromosome 22 hybrid cell line), a normal human control (GM03657), and hamster control cell line RJK88, digested with HindIII, BamHI, and EcoRI. Blots were washed at a final stringency of 0.1ϫ SSC, 0.2% SDS at 65°C and exposed to Kodak X-OMAT film at Ϫ70°C for 10 days.
PCR of RABL2A. To amplify specifically the copy of RABL2 encoded on chromosome 2, 100 ng of DNA from the chromosome 2 somatic hybrid cell line GM/NA10826B was used as a template to amplify a 1080-bp genomic DNA fragment that spans two exons. The primer pairs were RABLF1 and RABLR1 (5Ј CAC CCA GAC TTG GTT ACA AG 3Ј). The PCR product then was sequenced and compared to that of the cDNA.
Northern analysis. Human multiple tissue Northern blots were purchased from Clontech. Three probes were radioactively labeled and hybridized to the Northern blots consecutively: cDNA 504484, the unspliced intron at the 3Ј UTR of RABL2, and a ␤-actin control probe. The unspliced intron probe was amplified by PCR using 20 pmol of primers IIF (5Ј GGG TGG GTG GTG CCC TTT TA 3Ј, nucleotides 854 -874) and E1.03R (5Ј CTC AGG AGA AGC CCA AGG AA 3Ј, nucleotides 1258 -1238), with reverse transcription products from various tissues as templates (for PCR conditions see next section). The Northern blots were hybridized at 42°C overnight according to the manufacturer's instructions. The final washes of the blots were in 0.1ϫ SSPE, 0.1% SDS at 50°C. The blots were exposed to Kodak X-OMAT film at Ϫ70°C for 7 to 10 days.
Comparison of RABL2A and RABL2B expression level. Total RNA was isolated from cell lines GM/NA10826B, GM/NA10888, and various human tissues by TRIzol reagent (Gibco BRL). Reverse transcription was performed on ϳ1 g of total RNA, using ϳ10 pmol primer pul31 and 200 units of reverse transcriptase SuperScript II (Gibco BRL) at 42°C in a 20-l reaction. PCR was performed in triplicate for each tissue, with 20 mM Tris-Cl, pH 8.4, 50 mM KCl, 1.5 mM MgCl, 0.2 mM dNTPs, 1 l of the reverse transcription reaction as template, ϳ20 pmol primer RABLF1 (5Ј CCA CAG CAG CTG TCC ACG TA 3Ј, nucleotides 294 -314) and E0.91F, and ϳ2.5 U Taq polymerase in a 20-l reaction. PCR conditions were 25 cycles of 92°C for 30 s, 63°C minus 0.1°C/cycle for 30 s, and 72°C for 30 s, performed in a PTC 100 thermocycler (MJ Research) with a hot start and final extension at 72°C for 5 min. Reactions then were electrophoresed on 1% agarose gels with TAE buffer. PCR products were excised from the gel, purified by GeneClean (Bio101, La Jolla, CA), and digested with 10 U BsrGI (New England Biolab) at 60°C for 4 h to overnight. Digested products then were run on a 1% agarose gel. The band intensities of the BsrGI-uncleaved product (RABL2A) and BsrGI-cleaved product (RABL2B) were compared by eye. As a control experiment, partial cDNAs of RABL2A (using 1 ng 504484 cDNA as template) and RABL2B (using chromosome 22 cell line GM/NA10888 reverse transcription product as template) were amplified and subcloned into pGEM-T Easy vector (Promega). Once the sequence of the cDNA clones confirmed that no sequence errors were introduced during amplification, approximately 0.001 ng each of RABL2A and RABL2B cDNA clones were mixed in 1:0, 2:1, 1:1, 1:2, and 0:1 ratios and amplified using the same conditions as described above. Band intensities between PCR products that were digested (RABL2B) and were not digested (RABL2A) by BsrGI were compared by eye to determine whether the ratio of PCR products of the RABL2A and RABL2B clones matched approximately that in the ratio of the starting template DNA.
3Ј Rapid amplification of cDNA ends. Reverse transcription was performed using ϳ1 g of heart total RNA and ϳ10 pmol Gibco BRL poly(T) adapter primer (5Ј GGC CAC GCG TCG ACT ACT TTT TTT TTT TTT TTT T 3Ј). The reverse transcription product was purified by a GlassMax column (Gibco BRL) to remove poly(T) adapter primers. The purified reverse transcription product was eluted in a final volume of 40 l, and 5 l was used as a template for PCR. The PCR was performed using 20 pmol of pul51 and Gibco BRL universal amplification primers, with 2.5 U TaqPlus Precision PCR enzyme mix (Stratagene) in 30 cycles of 92°C for 30 s, 62°C minus 0.2°C/cycle for 30 s, and 72°C for 2 min with a hot start. PCR products were electrophoresed on 1% agarose gels in TAE buffer. Two major bands (1.7 and 0.7 kb) were excised from the gel, purified by GeneClean, and subcloned into pGEM-T Easy vector (Promega).
RESULTS

Genomic Organization of the Proximal Subtelomeric Domain of 22qter
A cosmid/P1 contig was previously constructed to span the 140-kb terminal deletion region of patient NT (Wong et al., 1997) . Four overlapping cosmid clones (N66C4, N85A3, N94H12, and N1G3) have now been sequenced by the "shotgun" method. The resulting sequences were deposited with GenBank under Accession Nos. AC000050, AC000036, AC002056, and AC002055, respectively. The end of the most distal cosmid, N1G3, is ϳ12 kb from the putative telomere of chromosome 22q, as defined by a P1 clone containing the telomere associated sequence TelBam3.4 (Ning et al., 1996) , which is usually located adjacent to the telomere (Brown et al., 1990) . To search for genes in this region, the 41 kb of N1G3 was subjected to a BLAST search for known nucleotide sequences and ESTs in the GenBank database. Directly proximal to the degenerate (TTAGGG) n boundary, and therefore presumably within the proximal subtelomeric domain, a putative gene was identified by an EST contig located at position 2584 -18,672 of N1G3. When the N1G3 sequence was searched against the TIGR Tentative Human Consensus (THC) sequence database, which assembles existing ESTs into contigs, there were more than 100 individual EST sequence entries. The 5Ј end of this EST contig is ϳ2.5 kb proximal to the degenerate (TTAGGG) n repeats (Fig. 1) , and its 3Ј end is 1.6 kb distal to a 16-kb cluster of the LINE/SINE repeats. EST clone 504484 spanning the entire EST contig was chosen for further analysis.
Duplication of the Subtelomeric Locus on Chromosomes 2q and 22q
When N1G3 was used as a probe for FISH, strong hybridization signals were found on 22qter and close to the centromere of 2q, and weaker signals were found on many different chromosome ends (data not shown). An overlapping cosmid c202, which contains the EST contig region and no distal subtelomeric domain, has been previously shown to map to 22qter and 2q13 by FISH (Ning et al., 1996) . When the cDNA clone 504484 was hybridized to a monochromosomal hybrid panel, hybridization signals were observed on chromosomes 2 and 22 (data not shown). To characterize this genomic region on the two chromosomes further, cDNA clone 504484 was hybridized to a partial hybrid panel that contained human chromosomes 2 and 22 and total human and hamster DNA digested with HindIII, BamHI, and EcoRI. The banding pattern of the chromosome 2 and 22 copies were identical using these three restriction enzymes. Figure 2 shows the pattern seen with EcoRI. The sizes of the restriction fragments on the partial hybrid panel matched those of the restriction map constructed by the GCG program MAP-SORT for cosmid N1G3 (Fig. 1) . This suggests that the duplication of this region was recent, since three sets of restriction sites are conserved. These two genes were named RABL2A (on chromosome 2) and RABL2B (on chromosome 22) due to their homology to the RAB family of genes (see below). Dosage analysis with the 1.6-kb region between the LINE/SINE cluster and the 3Ј end of RABL2B did not show the expected 2:1 ratio between normal human and NT microdeletion genomic DNAs (data not shown), suggesting that this region is duplicated and therefore the entire EST contig is within the proximal subtelomeric region.
Sequence Analysis of RABL2A and RABL2B
The entire 1056-bp cDNA clone 504484 was sequenced and revealed 10 exons when aligned against the sequence for cosmid N1G3 (Fig. 1) . The predicted ORF extends for 228 amino acids. Although the predicted translation start does not show a strong Kozak consensus sequence, there is an in-frame stop codon located nine nucleotides proximal to the first methionine. The 3Ј end of the cDNA does not have an apparent polyadenylation site. However, at least 16 other EST cDNAs end at the same position, as do three 3Ј RACE products (see below).
There were nine mismatches between the cDNA and N1G3, suggesting that this cDNA could originate from the other locus on chromosome 2. Therefore, a genomic fragment from chromosome 2 was amplified by PCR using the chromosome 2 hybrid cell line DNA as the template. Using primers RABLF1 and RABLR1 (Fig.1) , a 1081-bp fragment was produced containing exons 4 and 5, the sites of three of the mismatches. The sequence of cDNA 504484 identically matched the sequence of the chromosome 2 genomic DNA, indicating that this cDNA did originate from RABL2A. RT-PCR with total RNA from the chromosome 22 hybrid cell line as template, and RABLF1 and E0.91F as primers, produced a partial RABL2B cDNA that was identical to the genomic DNA sequence of chromosome 22 (data not shown). These results indicate that both RABL2A and RABL2B are expressed.
Comparison of the cDNA sequence of RABL2A with the genomic DNA of RABL2B revealed five nucleotide differences within the coding region that account for three differences in the predicted amino acid sequence (Fig. 3) : position 68 has a lysine (RABL2A) or an arginine (RABL2B); position 103 has a leucine (RABL2A) or a valine (RABL2B); and position 223 has a valine (RABL2A) or an alanine (RABL2B). All correspond to conservative amino acid differences. A BEAUTY search for protein similarities showed that both genes are members of the RAB family of GTPases. The RABL2s are most similar to yeast GTP-binding protein YPT8 (Accession No. P38555, 54% similarity over 183 amino acid residues), Dictyostelium discoideum RAB1A (Accession No. P34139, 56% similarity over 153 amino acid residues), and human RAB11A (Accession No. P24410, 54% protein similarity in 170 amino acid residues). Four of the five RAB protein conserved domains were found in the RABL2s (Fig. 3) . The fifth G5 guanine base-binding motif was not apparent.
Northern Analysis of the RABL2 Genes
A 2.5-kb transcript was detected in all adult and fetal tissues tested on Northern blots hybridized with the cDNA clone 504484 (Fig. 4a) . This transcript has a higher expression level in adult heart, brain, kidney, and pancreas than in placenta, lung, liver, and skeletal muscle. In fetal tissues, it has a stronger expression in brain than in lung. An ϳ1.4-kb alternative transcript 
FIG. 3.
The cDNA sequence of the RABL2A 2.5-kb transcript with its putative open reading frame. The predicted start codon is in boldface type. The nucleotides that differ in RABL2B are shown as lowercase letters above the sequence. The corresponding changes in amino acids are shown in boldface type below the amino acid residues. The exon boundaries are marked by a line between nucleotides. The was seen only in adult heart and skeletal muscle, with stronger expression than that of the 2.5-kb transcript in both tissues. Faint 4.4-kb and high-molecularweight transcripts appeared in some lanes (Fig. 4a) .
Cloning the 1.4-kb Alternative Transcript of RABL2 by 3Ј RACE
To clone the alternative 1.4-kb transcript found in heart and skeletal muscle, 3Ј RACE was performed as described under Materials and Methods using internal primer pul51 in exon 5 (Fig.1) . Using adult heart total RNA as a template, 3Ј RACE amplified both an ϳ1.7-and an ϳ0.7-kb product, presumed to correspond to the common 2.5-kb and the alternative 1.4-kb transcripts, respectively. The products were subcloned into pGEM-T Easy vector. Colonies that contained the clones of the 3Ј RACE products were hybridized to the cDNA clone 504484. Twenty-five clones had positive hybridization signals with the 1.7-kb product, and two clones hybridized to the 0.7-kb product. One 1.7-kb product clone (hc5) and two 0.7-kb product clones (hc7 and hc8) were completely sequenced. Analysis revealed that the 1.7-kb clone contains the ϳ1-kb intron between exons 9 and 10 in the 3Ј untranslated region (Fig. 3) . This intron is not found in either the 0.7-kb product or the cDNA clone 504484, which was isolated from a pregnant uterus cDNA library. This suggest that the alternative 1.4-kb muscle-specific transcript is the result of the splicing out of an intron in the 3Ј UTR, which is normally present in the common 2.5-kb transcript. To confirm this hypothesis, a probe from the intron (PCR product amplified by IIF and E1.03R primers, Fig. 1 ) was hybridized to a Northern blot. The intron probe hybridized to a 2.5-kb transcript but not a 1.4-kb transcript in any adult tissue (Fig. 4b) . The band intensity of this 2.5-kb transcript is similar to that on the Northern blot probed with cDNA clone 504484: adult heart, brain, kidney, and pancreas have a higher expression level than that in placenta, lung, liver, and skeletal muscle. The three 3ЈRACE products (hc5, hc7, and hc8) all ended at the same site as the cDNA, adding further evidence that this site represents the true end of the transcript. Including the unspliced intron sequence, 2114 bp of RABL2 has now been cloned, leaving ϳ400 bp unaccounted for and probably in the 5Ј UTR. cDNAs 504484, hc7, and hc8 difference between the two genes at nucleotide position 451 creates a BsrGI site in RABL2B but not RABL2A (TGTACA, dark gray shading). The amino acid sequences in boxes represent the four RAB functional domains G1 to G4 consecutively. The underlined sequence represents the intron that is spliced out in the 1.4-kb alternative transcript but is present in the 2.5-kb transcript. The RABL2A sequence is a compilation from cDNA clone 504484 (which does not contain the underlined intron) and a second cDNA (CCH) isolated from a CaCo2 cDNA library kindly provided by Dr. Johanna Rommens. RABL2B sequence differences were taken from N1G3 genomic sequence.
FIG. 4. Northern analysis of RABL2. (A)
Human multiple tissue Northern blots (Clontech) were probed with RABL2A cDNA 504484. A 2.5-kb transcript is present in every adult tissue, whereas a 1.4-kb transcript is present only in heart and skeletal muscle. Some lanes also show faint transcripts at 4.4 kb and near the origin. Comparison to the signal from the control probe ␤-actin is shown for normalization. (B) Adult multiple tissue Northern blot probed with the unspliced intron probe, showing only the 2.5-kb transcript. The control probe was GADPH. H, heart; B, brain; Pl, placenta; Lu, lung; Li, liver; S, skeletal muscle; K, kidney; Pa, pancreas; FB, fetal brain; FL, fetal lung.
were all determined to originate from RABL2A; therefore a RABL2B 1.4-kb transcript has not yet been identified.
Comparison of the Relative Expression Level between RABL2A and RABL2B
The specific expression pattern of each individual RABL2 gene was determined by RT-PCR. A difference in the sequence at position 451 in exon 6 results in the presence of a BsrGI restriction endonuclease site (TG-TACA) in RABL2B but not RABL2A. To determine whether this site could be used to differentiate the expression of the two loci, RABL2A and RABL2B partial cDNAs were mixed in different ratios for use as PCR templates as described under Materials and Methods. The partial cDNAs of the two RABL2s were amplified by PCR using primers RABLF1 and E0.91F (Fig. 1) and digested with BsrGI. The band intensity between the RABL2A 492-bp fragment and the RABL2B 368 ϩ 124-bp fragments were compared by eye. The ratio of the band intensity of the PCR products roughly matched that of the starting ratio of the templates (data not shown). Therefore, reverse transcription was performed in various tissues using the genespecific primer pul31 (Fig. 1) . The RABLF1/E0.91F fragment then was amplified using the RT products from different tissues as template. After BsrGI digestion, the RT-PCR products were run on a 1% agarose gel. The results from several experiments showed that both the 492-bp RABL2A product and the 368-bp RABL2B product were present in all tissues tested (Fig. 5) . Although the ratios of band intensity between the PCRs performed in triplicate from the same tissue were relatively even, the ratios varied somewhat when the PCR was repeated using the same RT product from each tissue. Among all the tissues tested, the expression levels of the two RABL2 genes in adult heart, skeletal muscle, small intestine, tonsil, thymus, fetal brain, and fetal lung were consistently even in two experiments. Placenta showed more RABL2B expression in two experiments, but more RABL2A expression in a third experiment. Adult liver showed low RABL2A expression consistently in three experiments (data not shown). Figure 5 shows that adult kidney has a very low level of RABL2B expression, but in another experiment the RABL2B expression was higher than that of RABL2A (data not shown). Although these experiments were not consistent enough to reveal subtle differences in the transcription levels between RABL2A and RABL2B, the results did confirm that both were expressed in all tissues tested.
DISCUSSION
We have identified two new members of the RAB gene family, which belongs to the RAS GTPase superfamily. To date, more than 40 mammalian RAB members have been described. RAB proteins are small GTPases involved in the control of vesicular trafficking in cells (reviewed by Lazar et al., 1997; Novick and Zerial, 1997; Olkkonen and Stenmark, 1997) . They regulate the transport vesicles between subcellular compartments or to and from the plasma membrane by a cycle of GDP/GTP exchange. Similar to all members of the RAS superfamily, RABs are small proteins with an average length of 200 to 300 amino acid residues. The RABL2s are 228 amino acids in length. A typical RAB protein contains five conserved domains: two guanine base-binding motifs (designated G4 and G5 by Lazar et al. (1997) ), two phosphate-Mg 2ϩ binding motifs (G1 and G3), and one effector region (G2). RABL2s have homologous G1 to G4 domains but lack G5. They also lack the cysteine-rich domain at the carboxyl terminus that is important for the binding of RABs to the vesicle membrane. The absence of the cysteine-rich domain suggests that RABL2s may be unable to bind to vesicle membranes and may therefore have a novel function unlike other RAB proteins. Since they do not have one of the two conserved guanine base-binding motifs, it is still to be proven that RABL2s are functional GTPases. The effector region, G2, determines the specificity of the RAB molecules. Each specific effector sequence interacts with different GTP activating proteins (GAP) or other putative effector molecules that act downstream of RAB (reviewed by Olkkonen and Stenmark, 1997) . The effector sequences are different in the two RABL2s (DGKTILVDF in RABL2A versus DGRTILVDF in RABL2B), although the amino acid difference is conservative. If the RABL2 effector region functions in a manner similar to other RABs, the difference between the effector sequence may give the two RABL2s slightly different functions.
RABL2s show a 2.5-kb transcript expressed ubiquitously and a 1.4-kb transcript with specific expression in heart and skeletal muscle. This size difference is the result of the presence or absence of an ϳ1-kb intron in the 3Ј UTR (Fig. 3) . Since the coding sequences of these two different sized transcripts are the same, the loss of
FIG. 5.
Comparison of the relative expression levels between RABL2A and RABL2B. RT-PCR was performed with different tissues to amplify the RABL2 partial cDNAs. The products then were digested with BsrGI and electrophoresed on 1% agarose gel. Three controls were included as templates in the RT-PCR experiment: the RABL2A-only cDNA, RABL2A and RABL2B cDNA mixed in 1:1 ratio, and the RABL2B-only cDNA. The upper band (492 bp) is the undigested RABL2A cDNA, and the lower bands (368 ϩ 124 bp) correspond to the BsrGI-digested RABL2B cDNA. Only one representative of each reaction is shown on this gel. FB, fetal brain; Pl, placenta; Li, liver; H, heart; K, kidney.
the intron in the muscle-specific 3Ј UTR is of unknown function. In general, the 3Ј UTR sequence can be involved in the stabilization of transcripts (Crowley and Hazelrigg, 1995; Miyamoto et al., 1996; Wilson et al., 1998) , subcellular localization of transcripts (Ainger et al., 1997; Macdonald and Kerr, 1997; Mahon et al., 1997) , posttranscriptional regulation (Kern et al., 1997; Savitsky et al., 1997) , translational repression (Hel et al., 1998) translational modification (Kollmus et al., 1996) , or tumor suppression (Jupe et al., 1996) . The unspliced intron occupies 1255 bp of the 3Ј UTR, and its removal leaves only 220 bp of 3Ј UTR. The intron contains an Alu element at position 1359 -1643, but no other consensus sequences have been identified. Differential splicing in a 3Ј UTR also has been found in the canine transducin ␤3 subunit gene (Akhmedov et al., 1997) , but the function of the two different UTRs is not known.
RABL2B is located in the telomeric region of 22q and oriented telomere to centromere. Although the 5Ј UTR of RABL2B has not yet been fully determined, the most distal known sequence of this gene is only 2.5 kb from the degenerate (TTAGGG) n repeat boundary domain between proximal and distal subtelomeric domains. Proximal domains are defined by long continuous regions of homology with a small number of different chromosome ends . The fact that RABL2B and RABL2A show identical restriction enzyme banding patterns with the three enzymes tested, and that the 1.6-kb region flanking the 3Ј end of the gene is also duplicated, indicates RABL2B is entirely within the proximal subtelomeric repeat. Although not mapped precisely to the fusion site of the two ancestral telomeres at 2q13, the mapping of RABL2A to this band suggests that both RABL2s map to proximal subtelomeric regions. This further suggests that the duplication of the RABL2 region may have been a subtelomeric event. If this is the case, then the duplication must have occurred before the fusion of the ape chromosomes to form human chromosome 2. Analysis of the RABL2 locus in the great apes could clarify this issue.
Since the distal subtelomeric domain is unlikely to contain any active genes, RABL2B is probably the last gene on chromosome 22q. RABL2B falls within the terminal microdeletion of patient NT, who shows mental retardation and expressive speech delay . Since the function of this novel protein is unknown, it is difficult to predict whether it is likely to be involved in the patient's abnormal phenotype. However, since both RABL2A and RABL2B are expressed and very close in sequence, this gene is unlikely to be dosage sensitive unless the two RABL2s have different functions. No RAB mutations have been associated with mental retardation; however, mutations of a RAB3-associated protein, ␣-GDI, have been shown to cause a form of X-linked nonspecific mental retardation in two families (D'Adamo et al., 1998) .
